Pan-immune-inflammation value for risk stratification of adverse cardiovascular outcomes in acute coronary syndrome undergoing percutaneous coronary intervention: a systematic review and meta-analysis - Poll - MDSpire

Pan-immune-inflammation value for risk stratification of adverse cardiovascular outcomes in acute coronary syndrome undergoing percutaneous coronary intervention: a systematic review and meta-analysis

  • By

  • Xinrui Yin

  • Shijia Du

  • June 1, 2026

  • 0 min

Share

Original Source(s)

Pan-immune-inflammation value for risk stratification of adverse cardiovascular outcomes in acute coronary syndrome undergoing percutaneous coronary intervention: a systematic review and meta-analysis

  • by Xinrui Yin, Shijia Du

  • June 1, 2026

Related Content

Heterogeneous benefit of early sacubitril/valsartan initiation after PCI in elderly patients with left ventricular dysfunction: myocardial recovery and mid-term cardiovascular outcomes

Overlapping Dual-Balloon Post-Dilation Technique for Enhanced Stent Expansion in Severely Dilated Coronary Arteries

Residual inflammatory risk post STEMI: high prevalence despite LDL-C control and association with other secondary prevention targets